Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 28, 2004
Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment
Anath Gafter-Gvili, Miron Prokocimer, William Breuer, et al.
Blood
|
May 25, 2004
Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia/HbE patients treated with an oral chelator
Pensri Pootrakul, William Breuer, Matias Sametband, et al.
British Journal of Pharmacology
|
November 25, 2010
Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal
Yang-Sung Sohn, Anna-Maria Mitterstiller, William Breuer, et al.
Blood
|
January 4, 2003
Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells
Gabriela Link, Prem Ponka, Abraham M Konijn, et al.
Blood
|
June 14, 2003
Labile plasma iron in iron overload: redox activity and susceptibility to chelation
Breno P Esposito, William Breuer, Pornpan Sirankapracha, et al.
Haematologica
|
December 20, 2011
The role of endocytic pathways in cellular uptake of plasma non-transferrin iron
Yang-Sung Sohn, Hussam Ghoti, William Breuer, et al.
American Journal of Hematology
|
November 30, 2011
Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients
William Breuer, Hussam Ghoti, Ahmmad Shattat, et al.
Blood
|
September 18, 2008
Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation
Or Kakhlon, Hila Manning, William Breuer, et al.
Blood
|
July 13, 2006
Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences
Hava Glickstein, Rinat Ben El, Gabi Link, et al.
Diabetes Care
|
October 27, 2004
Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes
Mahmoud Sulieman, Rabea Asleh, Zvi I Cabantchik, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 28, 2004
Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment
Anath Gafter-Gvili, Miron Prokocimer, William Breuer, et al.
Blood
|
May 25, 2004
Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia/HbE patients treated with an oral chelator
Pensri Pootrakul, William Breuer, Matias Sametband, et al.
British Journal of Pharmacology
|
November 25, 2010
Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal
Yang-Sung Sohn, Anna-Maria Mitterstiller, William Breuer, et al.
Blood
|
January 4, 2003
Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells
Gabriela Link, Prem Ponka, Abraham M Konijn, et al.
Blood
|
June 14, 2003
Labile plasma iron in iron overload: redox activity and susceptibility to chelation
Breno P Esposito, William Breuer, Pornpan Sirankapracha, et al.
Haematologica
|
December 20, 2011
The role of endocytic pathways in cellular uptake of plasma non-transferrin iron
Yang-Sung Sohn, Hussam Ghoti, William Breuer, et al.
American Journal of Hematology
|
November 30, 2011
Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients
William Breuer, Hussam Ghoti, Ahmmad Shattat, et al.
Blood
|
September 18, 2008
Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation
Or Kakhlon, Hila Manning, William Breuer, et al.
Blood
|
July 13, 2006
Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences
Hava Glickstein, Rinat Ben El, Gabi Link, et al.
Diabetes Care
|
October 27, 2004
Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes
Mahmoud Sulieman, Rabea Asleh, Zvi I Cabantchik, et al.
Page
of 3